As the nutraceutical industry shifts toward personalised, life-stage-specific wellness, innovative botanical ingredients tailored to meet the evolving needs of women are necessary – from adolescence through post menopause.
The global women’s health supplement market is growing, driven by increasing awareness around hormonal balance, reproductive health, bone strength and healthy ageing. Yet, despite this growth, several gaps remain.
Many women are under-served in key life phases, particularly perimenopause and post menopause, where symptoms are often normalised rather than addressed. Issues such as menstrual irregularities, hormonal imbalances, reduced mobility, mood fluctuations and sexual health concerns are still stigmatised, underdiagnosed or inadequately treated with one-size-fits-all solutions.
A major challenge lies in the lack of stage-specific nutritional support – with most products focusing on general wellness or isolated symptom relief. Additionally, natural ingredients often face challenges related to standardisation and bioavailability of the active constituents present, making it difficult for consumers to achieve consistent, noticeable results.
This highlights the importance of high-quality, clinically-validated botanical solutions that not only align with women’s physiological needs across life stages but also ensure efficacy through innovative delivery formats. Supplementation, when precisely formulated, can play a critical role in bridging the nutritional gaps, modulating hormonal health and enhancing overall quality of life.
With a strong foundation in traditional botanical wisdom and supported by modern clinical science, Ennature Biopharma’s newest launches – Gingeren®, Aspargize™, and Maxicuma® – represent a comprehensive, phase-specific approach to women’s health. Each ingredient addresses key physical and functional wellness concerns using standardised extracts and advanced delivery technologies designed for measurable, real-world efficacy.
From first cycle to postmenopause
As women progress through life, their health priorities continuously evolve with common wellness concerns across each major phase:
- Reproductive years Support for menstrual regularity, energy and reproductive wellness becomes key.
- Perimenopause and menopause This phase brings changes in temperature regulation, sleep, mood and overall comfort.
- Postmenopause Reduced estrogen levels can influence bone density, mobility and metabolic and cognitive functions – demanding more comprehensive support.
- Adolescence and early reproductive years Dysmenorrhea affects up to 90% of young women, often impacting daily life, academic performance and emotional wellbeing.
Sustained-release gingerols for menstrual comfort and beyond
Menstrual health, though being crucial to women’s overall wellbeing – remains overlooked. Each month, women experience a range of symptoms including abdominal cramps, lower back pain, mood fluctuations and fatigue, all of which can disrupt productivity, emotional balance and quality of life.
Despite the high prevalence of menstrual discomfort – particularly among adolescents and women in their twenties – supportive solutions are often limited to temporary relief or Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) with side effects.
Derived from ginger and standardised to 20% total gingerols, Gingeren addresses challenges such as the pharmacokinetic profile of botanicals which require ingredients to be taken in high doses, causing difficulties due to its low tolerability and pungent nature.
Conventional ginger extracts can be rapidly metabolised and eliminated. Gingeren overcomes this with a patented sustained-release system that extends the half-life of active compounds by up to five times, improving both duration and tolerability.
A clinical trial, due to be completed by December 2025, showed that with supplementation of 200 mg/day Gingeren can support:
- Relief from menstrual cramps and discomfort
- Mood and behavioural balance during menstruation
- Broader benefits in immune health, GI support and female sexual wellness
Full-spectrum shatavari for menopause support
Shatavari (Asparagus racemosus) is revered in Ayurveda as the ‘Queen of Herbs’. It is widely known for promoting female vitality, lactation and reproductive wellness through its rich profile of steroidal saponins – particularly shatavarins – that exert phytoestrogenic activity while interacting with estrogen and progesterone receptors, maintaining healthy endocrine balance.
Aspargize is a full-spectrum root extract standardised to contain over 5% total shatavarins, combining both steroidal and non-steroidal saponins for a broad phytochemical effect.
Enhanced with a natural bio-enhancing complex, Aspargize is designed to deliver effective support for women in perimenopause and postmenopause, particularly for:
- Hot flashes and night sweats
- Fatigue and reduced vitality
- Mood balance and daily wellness
In a clinical study, due to be completed by September 2025, Aspargize supplemented at 400 mg/day is shown to offer brands a versatile, low-dose ingredient ideal for clean-label formulations.
Liposomal curcumin for joint and mobility support
Curcumin remains one of the most sought-after nutraceuticals globally, but bioavailability challenges (extensive first pass metabolism) have limited its potential – until now.
Maxicuma is formulated using LIMAN™, Ennature’s proprietary Lecithin-based Liposomal Microencapsulation technology, delivering 172 times more free curcumin in human plasma compared to conventional extracts. It is standardised to 40% curcuminoids, Self-Affirmed GRAS, and Clean Label Project Verified.
A clinical study, currently under peer review, showed at ultra-low doses of 100–250 mg/day Maxicuma can:¹
- Improve joint comfort and flexibility
- Enhance mobility and physical performance
- Support healthy ageing, particularly for midlife and older women
Its versatility allows application across formats including capsules, gummies, RTDs and functional nutrition products with convenience, taste and efficacy compatibility.
The future of women’s wellness
As the global nutraceutical market shifts toward personalised, life-stage solutions, Ennature Biopharma continues to lead with clinically supported, high-performance botanical ingredients designed for real consumer outcomes.
To explore formulation concepts, clinical data, or partnership opportunities, visit Ennature Biopharma at Booth #G40 at Vitafoods Asia 2025.
References
- MaxiCuma. Supports Healthy Joints.
